Dr. Reddy’s Launches Made-in-India Nivolumab Biosimilar NIVORZ Across 12 Cancer Indications
Developed and manufactured entirely in-house at Dr. Reddy’s biologics facility in Bachupally, Hyderabad, NIVORZ marks the company’s entry into biosimilar immuno-oncology in the Indian market. The launch also expands the presence of domestically manufactured biosimilars in a field of cancer treatment where access and treatment costs remain major concerns.